Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-06-22 | Alan P. Timmins (10) Includes: 36,986 shares of Common Stock subject to an option held directly by Mr. Timmins. |
| 2020-09-01 | Mr. Timmins holds a B.B.A. degree from the University of Portland and a M.B.A. from Stanford University. Mr. Timmins brings a wealth of financial and operations experience to CytoDyn’s board. |
Data sourced from SEC filings. Last updated: 2026-02-03